JP2011528037A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528037A5 JP2011528037A5 JP2011518838A JP2011518838A JP2011528037A5 JP 2011528037 A5 JP2011528037 A5 JP 2011528037A5 JP 2011518838 A JP2011518838 A JP 2011518838A JP 2011518838 A JP2011518838 A JP 2011518838A JP 2011528037 A5 JP2011528037 A5 JP 2011528037A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorph
- salt
- ethoxy
- methyl
- dihydrothiazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 claims 15
- -1 2-hydroxy-3- (2- (2- (2-methoxyethoxy) ethoxy) ethoxy) phenyl Chemical group 0.000 claims 8
- 239000011777 magnesium Substances 0.000 claims 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- 229910052751 metal Inorganic materials 0.000 claims 5
- 239000002184 metal Substances 0.000 claims 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 3
- 229910052749 magnesium Inorganic materials 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical group CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 2
- 229910052742 iron Inorganic materials 0.000 claims 2
- 229910052747 lanthanoid Inorganic materials 0.000 claims 2
- 150000002602 lanthanoids Chemical class 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 206010065973 Iron Overload Diseases 0.000 claims 1
- 235000019766 L-Lysine Nutrition 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 1
- 229930064664 L-arginine Natural products 0.000 claims 1
- 235000014852 L-arginine Nutrition 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims 1
- 229960002885 histidine Drugs 0.000 claims 1
- MVAWDZLMOYASSX-JPKZNVRTSA-L magnesium (4S)-2-[2-hydroxy-3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]-4-methyl-5H-1,3-thiazole-4-carboxylate hydroxide Chemical compound [OH-].[Mg+2].COCCOCCOCCOC1=CC=CC(C=2SC[C@@](C)(N=2)C([O-])=O)=C1O MVAWDZLMOYASSX-JPKZNVRTSA-L 0.000 claims 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 claims 1
- 239000011654 magnesium acetate Substances 0.000 claims 1
- 229940069446 magnesium acetate Drugs 0.000 claims 1
- 235000011285 magnesium acetate Nutrition 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 229960000281 trometamol Drugs 0.000 claims 1
- 239000004246 zinc acetate Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8057208P | 2008-07-14 | 2008-07-14 | |
| US61/080,572 | 2008-07-14 | ||
| US15257209P | 2009-02-13 | 2009-02-13 | |
| US61/152,572 | 2009-02-13 | ||
| PCT/US2009/050532 WO2010009120A2 (en) | 2008-07-14 | 2009-07-14 | Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011528037A JP2011528037A (ja) | 2011-11-10 |
| JP2011528037A5 true JP2011528037A5 (enExample) | 2012-08-30 |
Family
ID=41550988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518838A Pending JP2011528037A (ja) | 2008-07-14 | 2009-07-14 | 金属キレート化剤としてのデスアザデスフェリチオシンポリエーテル類似体の新規の塩及び多形体 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US8063227B2 (enExample) |
| EP (1) | EP2303853A4 (enExample) |
| JP (1) | JP2011528037A (enExample) |
| KR (1) | KR20110039347A (enExample) |
| CN (2) | CN102149700A (enExample) |
| AU (1) | AU2009271074B2 (enExample) |
| CA (1) | CA2728636A1 (enExample) |
| IL (2) | IL210294A (enExample) |
| MX (1) | MX2011000486A (enExample) |
| MY (1) | MY163516A (enExample) |
| NZ (2) | NZ590302A (enExample) |
| WO (1) | WO2010009120A2 (enExample) |
| ZA (1) | ZA201100311B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003270473A1 (en) | 2003-09-09 | 2005-04-27 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
| ES2732625T3 (es) | 2005-04-04 | 2019-11-25 | Univ Florida | Análogos de poliéter de desferritiocina |
| CN104003955A (zh) | 2007-03-15 | 2014-08-27 | 佛罗里达大学研究基金公司 | 去铁硫辛聚醚类似物 |
| CN102149700A (zh) | 2008-07-14 | 2011-08-10 | 法罗肯生物科学公司 | 作为金属螯合剂的脱氮杂去铁硫辛聚醚类似物的新型盐和多晶型物 |
| BR112012001761A2 (pt) * | 2009-07-27 | 2017-05-09 | Ferrokin Bioscience Inc | composto de formula i, composto farmacêutica e método de tratamento de uma condição mediada por metal em um indivduo |
| EP2566854A4 (en) * | 2010-05-04 | 2013-11-06 | Shire Llc | DESAZADESFERROTHIOCIN AND DEAZADESFERROTHIOCIN POLYETHER ANALOGS AS METAL CHELATORS |
| CA2857990A1 (en) * | 2011-12-09 | 2013-06-13 | Ferrokin Biosciences, Inc. | Oral formulations for treating metal overload |
| BR112014014544A2 (pt) | 2011-12-16 | 2017-06-13 | Univ Florida | usos de análogos de 4'-desferritiocina |
| WO2014089482A1 (en) * | 2012-12-07 | 2014-06-12 | Ferrokin Biosciences, Inc. | Polymorph forms of desazadesferrithiocin analogs |
| HK1220194A1 (zh) * | 2013-03-15 | 2017-04-28 | Ferrokin Biosciences, Inc. | 去氮杂去铁硫代霉素(desazadesferrithiocin)类似物的多晶型形式 |
| US10010535B2 (en) | 2013-11-22 | 2018-07-03 | University Of Florida Research Foundation, Incorporated | Desferrithiocin analogs and uses thereof |
| TWI695717B (zh) | 2014-03-06 | 2020-06-11 | 美商 Ptc 治療公司 | １,２,４-二唑苯甲酸之鹽及醫藥組合物 |
| WO2016176343A1 (en) | 2015-04-27 | 2016-11-03 | University Of Florida Research Foundation, Incorporated | Metabolically programmed metal chelators and uses thereof |
| US10446309B2 (en) | 2016-04-20 | 2019-10-15 | Vishay Dale Electronics, Llc | Shielded inductor and method of manufacturing |
| CN107119083A (zh) * | 2017-04-28 | 2017-09-01 | 江苏梦得新材料科技有限公司 | 一种生物酶法制备聚二硫二丙烷磺酸钠的方法 |
| CN107174917A (zh) * | 2017-05-01 | 2017-09-19 | 蒋里军 | 粘土矿物治霾方法及其摩天大楼治霾烟囱 |
| CN108264892A (zh) * | 2017-12-21 | 2018-07-10 | 东北农业大学 | 一种用于释放地下油质材料的表面活性剂的组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083966A (en) | 1998-08-31 | 2000-07-04 | University Of Florida | Thiazoline acid derivatives |
| AT500490A1 (de) * | 2001-10-16 | 2006-01-15 | Dsm Fine Chem Austria Gmbh | Verfahren zur herstellung von substituierten thiazolinen und deren zwischenprodukte |
| US20040132789A1 (en) * | 2002-08-22 | 2004-07-08 | University Of Florida | Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| JPWO2004031163A1 (ja) * | 2002-10-01 | 2006-02-02 | 株式会社カネカ | 光学活性α−置換システインまたはその塩の製造方法並びにその合成中間体及びその製造方法 |
| ATE400300T1 (de) | 2003-09-09 | 2008-07-15 | Univ Florida | Polyamin-metallchelatbildner-konjugate |
| AU2003270473A1 (en) | 2003-09-09 | 2005-04-27 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
| ES2732625T3 (es) * | 2005-04-04 | 2019-11-25 | Univ Florida | Análogos de poliéter de desferritiocina |
| US20080138440A1 (en) * | 2006-11-29 | 2008-06-12 | Cormedix Inc. | Methods of diagnosing and alleviating gadolinium toxicity |
| US20100137346A1 (en) | 2006-12-12 | 2010-06-03 | University Of Florida Research Foundation, Inc. | Desferrithiocin analogue actinide decorporation agents |
| CN104003955A (zh) * | 2007-03-15 | 2014-08-27 | 佛罗里达大学研究基金公司 | 去铁硫辛聚醚类似物 |
| CN102149700A (zh) | 2008-07-14 | 2011-08-10 | 法罗肯生物科学公司 | 作为金属螯合剂的脱氮杂去铁硫辛聚醚类似物的新型盐和多晶型物 |
| BR112012001761A2 (pt) | 2009-07-27 | 2017-05-09 | Ferrokin Bioscience Inc | composto de formula i, composto farmacêutica e método de tratamento de uma condição mediada por metal em um indivduo |
| CA2772212A1 (en) | 2009-08-25 | 2011-03-10 | University Of Florida Research Foundation, Inc. | Desferrithiocin polyether analogues and uses thereof |
| EP2566854A4 (en) | 2010-05-04 | 2013-11-06 | Shire Llc | DESAZADESFERROTHIOCIN AND DEAZADESFERROTHIOCIN POLYETHER ANALOGS AS METAL CHELATORS |
-
2009
- 2009-07-14 CN CN2009801359235A patent/CN102149700A/zh active Pending
- 2009-07-14 MX MX2011000486A patent/MX2011000486A/es active IP Right Grant
- 2009-07-14 NZ NZ590302A patent/NZ590302A/xx not_active IP Right Cessation
- 2009-07-14 CN CN201310322314.9A patent/CN103435569B/zh not_active Expired - Fee Related
- 2009-07-14 WO PCT/US2009/050532 patent/WO2010009120A2/en not_active Ceased
- 2009-07-14 KR KR1020117003382A patent/KR20110039347A/ko not_active Ceased
- 2009-07-14 US US12/502,559 patent/US8063227B2/en not_active Expired - Fee Related
- 2009-07-14 JP JP2011518838A patent/JP2011528037A/ja active Pending
- 2009-07-14 EP EP09798650A patent/EP2303853A4/en not_active Ceased
- 2009-07-14 MY MYPI2010006096A patent/MY163516A/en unknown
- 2009-07-14 AU AU2009271074A patent/AU2009271074B2/en not_active Ceased
- 2009-07-14 CA CA2728636A patent/CA2728636A1/en not_active Abandoned
- 2009-07-14 NZ NZ605452A patent/NZ605452A/en not_active IP Right Cessation
-
2010
- 2010-12-27 IL IL210294A patent/IL210294A/en not_active IP Right Cessation
-
2011
- 2011-01-12 ZA ZA2011/00311A patent/ZA201100311B/en unknown
- 2011-03-07 US US13/042,193 patent/US8829197B2/en not_active Expired - Fee Related
- 2011-08-04 US US13/198,287 patent/US8710087B2/en not_active Expired - Fee Related
- 2011-10-06 US US13/267,285 patent/US8846731B2/en not_active Expired - Fee Related
-
2014
- 2014-03-17 IL IL231558A patent/IL231558A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010521471A5 (enExample) | ||
| JP2024516371A5 (enExample) | ||
| JP2009545527A5 (enExample) | ||
| ME02307B (me) | Kristalni (r)-(e)-2-(4-(2-(5-(1-(3,5-diklorpiridin-4-il)etoksi)-1h-indazol- 3-il)vinil)-1h-pirazol-1-il)etanol i njegova upotreba kao inhibitora fgfr | |
| JP2009502793A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| JP2007522220A5 (enExample) | ||
| JP2018024682A5 (enExample) | ||
| JP2016522835A5 (enExample) | ||
| JP2007302689A5 (enExample) | ||
| JP2014532638A5 (enExample) | ||
| SI3004090T1 (en) | Chemical compounds | |
| JP2014012726A5 (enExample) | ||
| JP2014521744A5 (enExample) | ||
| JP2008501000A5 (enExample) | ||
| JP2013512277A5 (enExample) | ||
| JP2009543795A5 (enExample) | ||
| JP2020510661A5 (enExample) | ||
| JP2013518832A5 (enExample) | ||
| JP2010521516A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| JP2013507442A5 (enExample) | ||
| JP2007515467A5 (enExample) | ||
| JP2013511511A5 (enExample) | ||
| JP2019151627A5 (enExample) |